[18F]-FDG Uptake as a Marker of Residual Anaplastic and Poorly Differentiated Thyroid Carcinoma following BRAF-Targeted Therapy

Samir A. Dagher; Kim O. Learned; Richard Dagher; Jennifer Rui Wang; Xiao Zhao; S. Mohsen Hosseini; Anastasios Maniakas; Maria E. Cabanillas; Naifa L. Busaidy; Ramona Dadu; Priyanka Iyer; Mark E. Zafereo; Alexander M. Khalaf

doi:10.3174/ajnr.A8588

Research ArticleHEAD AND NECK IMAGING

[¹⁸F]-FDG Uptake as a Marker of Residual Anaplastic and Poorly Differentiated Thyroid Carcinoma following BRAF-Targeted Therapy

Samir A. Dagher, Kim O. Learned, Richard Dagher, Jennifer Rui Wang, Xiao Zhao, S. Mohsen Hosseini, Anastasios Maniakas, Maria E. Cabanillas, Naifa L. Busaidy, Ramona Dadu, Priyanka Iyer, Mark E. Zafereo and Alexander M. Khalaf

American Journal of Neuroradiology May 2025, DOI: https://doi.org/10.3174/ajnr.A8588

Samir A. Dagher

aFrom the Department of Neuroradiology/Head and Neck Imaging (S.A.M., K.O.L., R.D., A.M.K), The University of Texas MD Anderson Cancer Center, Houston, Texas

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Samir A. Dagher

Kim O. Learned

aFrom the Department of Neuroradiology/Head and Neck Imaging (S.A.M., K.O.L., R.D., A.M.K), The University of Texas MD Anderson Cancer Center, Houston, Texas

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Kim O. Learned

Richard Dagher

aFrom the Department of Neuroradiology/Head and Neck Imaging (S.A.M., K.O.L., R.D., A.M.K), The University of Texas MD Anderson Cancer Center, Houston, Texas

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Richard Dagher

Jennifer Rui Wang

bDepartment of Head and Neck Surgery (J.R.W., X.Z., A.M., M.E.Z.), The University of Texas MD Anderson Cancer Center, Houston, Texas

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Xiao Zhao

bDepartment of Head and Neck Surgery (J.R.W., X.Z., A.M., M.E.Z.), The University of Texas MD Anderson Cancer Center, Houston, Texas

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

S. Mohsen Hosseini

cDepartment of Pathology (S.M.H.), The University of Texas MD Anderson Cancer Center, Houston, Texas

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Anastasios Maniakas

bDepartment of Head and Neck Surgery (J.R.W., X.Z., A.M., M.E.Z.), The University of Texas MD Anderson Cancer Center, Houston, Texas

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Maria E. Cabanillas

dDepartment of Endocrine Neoplasia and Hormonal Disorders (M.E.C., N.L.B., R.D., P.I.), The University of Texas MD Anderson Cancer Center, Houston, Texas

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Maria E. Cabanillas

Naifa L. Busaidy

dDepartment of Endocrine Neoplasia and Hormonal Disorders (M.E.C., N.L.B., R.D., P.I.), The University of Texas MD Anderson Cancer Center, Houston, Texas

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Ramona Dadu

dDepartment of Endocrine Neoplasia and Hormonal Disorders (M.E.C., N.L.B., R.D., P.I.), The University of Texas MD Anderson Cancer Center, Houston, Texas

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Priyanka Iyer

dDepartment of Endocrine Neoplasia and Hormonal Disorders (M.E.C., N.L.B., R.D., P.I.), The University of Texas MD Anderson Cancer Center, Houston, Texas

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Mark E. Zafereo

bDepartment of Head and Neck Surgery (J.R.W., X.Z., A.M., M.E.Z.), The University of Texas MD Anderson Cancer Center, Houston, Texas

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Mark E. Zafereo

Alexander M. Khalaf

aFrom the Department of Neuroradiology/Head and Neck Imaging (S.A.M., K.O.L., R.D., A.M.K), The University of Texas MD Anderson Cancer Center, Houston, Texas

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Alexander M. Khalaf

Article
Figures & Data
Supplemental
Info & Metrics
Responses
References
PDF

Submit a Response to This Article

Compose eLetter

Title *

Contents

More information about text formats

Plain text

No HTML tags allowed.
Web page addresses and e-mail addresses turn into links automatically.
Lines and paragraphs break automatically.

Author Information

Contributors
First Name and Middle Initial * First or given name, e.g. 'Peter'. Last Name * Your last, or family, name, e.g. 'MacMoody'. Email Address * Your email address, e.g. [email protected] Occupation * Your role and/or occupation, e.g. 'Orthopedic Surgeon'. Affiliation * Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.

Statement of Competing Interests

Competing interests? *

Yes

Please describe the competing interests

Vertical Tabs

Jump to comment:

No eLetters have been published for this article.

PreviousNext

Download PDF

Email Article

Thank you for your interest in spreading the word on American Journal of Neuroradiology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following [18F]-FDG Uptake as a Marker of Residual Anaplastic and Poorly Differentiated Thyroid Carcinoma following BRAF-Targeted Therapy

Message Subject (Your Name) has sent you a message from American Journal of Neuroradiology

Message Body (Your Name) thought you would like to see the American Journal of Neuroradiology web site.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Cite this article

[¹⁸F]-FDG Uptake as a Marker of Residual Anaplastic and Poorly Differentiated Thyroid Carcinoma following BRAF-Targeted Therapy

American Journal of Neuroradiology May 2025, DOI: 10.3174/ajnr.A8588

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

0 Responses

Respond to this article

Bookmark this article

User Name *

Password *

Remember my user name & password.

FDG Uptake and Thyroid Cancer Post-BRAF Therapy

American Journal of Neuroradiology May 2025, DOI: 10.3174/ajnr.A8588

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Purchase

Jump to section

Article
Figures & Data
Supplemental
Info & Metrics
Responses
References
PDF

PubMed
Google Scholar

Cited By...

No citing articles found.

Crossref
Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Main menu

User menu

Search

American Journal of Neuroradiology

[¹⁸F]-FDG Uptake as a Marker of Residual Anaplastic and Poorly Differentiated Thyroid Carcinoma following BRAF-Targeted Therapy

Plain text

Vertical Tabs

Jump to comment:

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Similar Articles

Indexed Content

Cases

More from AJNR

Multimedia

Resources

About Us

American Society of Neuroradiology